Literature DB >> 24793788

Understanding bone safety zones during bone marrow aspiration from the iliac crest: the sector rule.

Jacques Hernigou1, Laure Picard, Alexandra Alves, Jonathan Silvera, Yasuhiro Homma, Philippe Hernigou.   

Abstract

PURPOSE: Should the trocar suddenly lose contact with bone during bone marrow aspiration, it may result in visceral injury. The anatomy of the ilium and the structures adjacent to the iliac bone were studied to determine the danger of breach by a trocar introduced into the iliac crest.
METHODS: The authors followed two series of patients, one series to do measurements of distance and angles of the structures at risk to the iliac bone and the other to evaluate the risk of a trocar being directed outside the iliac wing during bone marrow aspiration. The authors also examined 24 pelvices by computed tomography (CT) scans of mature adults (48 iliac crests). Lines dividing the iliac wing into six equal sectors were used to form sectors (e.g. sector 1 anterior, sector 6 posterior). Vascular or neurological structures were considered at risk if they were accessible to the tip of a 10-cm trocar introduced into the iliac crest with a possible deviation of 20° from the plane of the iliac wing on the three-dimensional reconstruction. The authors tracked bone marrow aspiration of six different surgeons and calculated among 120 patients (480 entry points) the number of times the needle lost contact with bone in each sector of aspiration.
RESULTS: The sector system reliably predicted safe and unsafe areas for trocar placement. Among the 480 entry points in the 120 patients, 94 breaches were observed and higher risks were observed in the thinner sectors. The risk was also higher in obese patients and the risk decreased with more experienced surgeons. The trocar could reach the external iliac artery on pelvic CT scans in the four most anterior sectors with a higher frequency in women. Posterior sectors were at risk for sciatic nerve and gluteal vessel damage when the trocar was pushed deeper than 6 cm into the posterior iliac crest. In cadavers, the dissection demonstrated nine vascular or neurological lesions.
CONCLUSIONS: Using the sector system, trocars can be directed away from neural and vascular structures and toward zones that are likely to contain larger bone marrow stock.

Entities:  

Mesh:

Year:  2014        PMID: 24793788     DOI: 10.1007/s00264-014-2343-9

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  17 in total

1.  Treatment of osteonecrosis with autologous bone marrow grafting.

Authors:  Philippe Hernigou; Françoise Beaujean
Journal:  Clin Orthop Relat Res       Date:  2002-12       Impact factor: 4.176

2.  Bone marrow biopsy morbidity: review of 2003.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

3.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

4.  Impact of iliac crest bone graft harvesting on fusion rates and postoperative pain during instrumented posterolateral lumbar fusion.

Authors:  Constantin Schizas; Dimitrios Triantafyllopoulos; Victor Kosmopoulos; Kosmas Stafylas
Journal:  Int Orthop       Date:  2007-08-28       Impact factor: 3.075

5.  Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty.

Authors:  Philippe Hernigou; Jacques Pariat; Steffen Queinnec; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-02-09       Impact factor: 3.075

6.  Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate.

Authors:  Philippe Hernigou; Yasuhiro Homma; Charles-Henri Flouzat-Lachaniette; Alexandre Poignard; Nathalie Chevallier; Helene Rouard
Journal:  J Bone Joint Surg Am       Date:  2013-12-18       Impact factor: 5.284

7.  Bone-marrow biopsy of the iliac bone followed by severe retroperitoneal hemorrhage.

Authors:  L M Pedersen; D Jarner; J Winge
Journal:  Eur J Haematol       Date:  1993-07       Impact factor: 2.997

8.  A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7.

Authors:  Z Dahabreh; G M Calori; N K Kanakaris; V S Nikolaou; P V Giannoudis
Journal:  Int Orthop       Date:  2008-12-04       Impact factor: 3.075

9.  A rare case of massive retroperitoneal hemorrhage after bone marrow aspiration alone.

Authors:  Hsien-Lung Tsai; Shih-Wei Liu; Chorng-Kuang How; Chii-Hwa Chern; David Hung-Tsang Yen; Chun-I Huang
Journal:  Am J Emerg Med       Date:  2008-11       Impact factor: 2.469

10.  Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.

Authors:  Berthold Amann; Claas Luedemann; Richard Ratei; J André Schmidt-Lucke
Journal:  Cell Transplant       Date:  2009-04-02       Impact factor: 4.064

View more
  19 in total

1.  Anatomic feasibility of a new endopelvic approach for iliac crest bone harvesting.

Authors:  S Le Pape; L Du Pouget; T Cloche; M Campana; I Obeid; L Boissiere; J-M Vital
Journal:  Surg Radiol Anat       Date:  2016-05-09       Impact factor: 1.246

Review 2.  Ultrasound imaging and guidance in the management of knee osteoarthritis in regenerative medicine field.

Authors:  Alper Murat Ulasli; Levent Ozcakar; William D Murrel
Journal:  J Clin Orthop Trauma       Date:  2018-11-30

3.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

Review 4.  Stem Cell Considerations for the Clinician.

Authors:  Karen A Hasty; Hongsik Cho
Journal:  Phys Med Rehabil Clin N Am       Date:  2016-11       Impact factor: 1.784

5.  Reorientation technique has benefits in bone marrow aspiration of stem cells.

Authors:  Christof Pabinger; Dietmar Dammerer; Harald Lothaller; Georg Stefan Kobinia
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

Review 6.  The history of bone marrow in orthopaedic surgery (part I trauma): trepanning, bone marrow injection in damage control resuscitation, and bone marrow aspiration to heal fractures.

Authors:  Philippe Hernigou
Journal:  Int Orthop       Date:  2020-02-15       Impact factor: 3.075

7.  Treatment of simple bone cyst with bone marrow concentrate and equine-derived demineralized bone matrix injection versus methylprednisolone acetate injections: A retrospective comparative study.

Authors:  Raffaele Dario D'Amato; Antonio Memeo; Federico Fusini; Elena Panuccio; Giuseppe Peretti
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

8.  Subchondral stem cell therapy versus contralateral total knee arthroplasty for osteoarthritis following secondary osteonecrosis of the knee.

Authors:  Philippe Hernigou; Jean Charles Auregan; Arnaud Dubory; Charles Henri Flouzat-Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2018-03-27       Impact factor: 3.075

9.  Defining the iliac wing osseous fixation pathways: anatomy and implant constriction points.

Authors:  Miqi Wang; Robert C Jacobs; Craig S Bartlett; Patrick C Schottel
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-03       Impact factor: 3.067

Review 10.  Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles-Henri Flouzat-Lachaniette
Journal:  Clin Orthop Surg       Date:  2016-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.